Apyx Medical Corp (APYX)

3.08USD +2.67% (+0.08)

Over 5Y: -72.3%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 10 15
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -4M Q4 '21 — Operating Income: -1.7M Q1 '22 — Operating Income: -5.9M Q2 '22 — Operating Income: -6M Q3 '22 — Operating Income: -5.8M Q4 '22 — Operating Income: -5.9M Q1 '23 — Operating Income: -5.6M Q2 '23 — Operating Income: -1.2M Q3 '23 — Operating Income: -4.6M Q4 '23 — Operating Income: -5.8M Q1 '24 — Operating Income: -6.6M Q2 '24 — Operating Income: -5.5M Q3 '24 — Operating Income: -3.6M Q4 '24 — Operating Income: -3M Q1 '25 — Operating Income: -3.1M Q2 '25 — Operating Income: -2.6M Q3 '25 — Operating Income: -832K Q4 '25 — Operating Income: 11K Q1 '26 — Operating Income: -911K Q2 '26 — Operating Income: -1.8M -6M -4.5M -3M -1.5M 0 1.5M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.7
OE margin -23.0%
Oper. margin -6.1%
Gross margin 63.5%
Accruals 2.4%
FCF margin -18.9%
OCF margin -17.3%
Profit margin -14.8%
ROA -14.1%
ROCE -6.8%
ROE -81.0%
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 1.7×
EV/OE -7.4×
P/C 1.9×
EV/GP 2.7×
FCF yield -8.5%
P/B 12.2×
Div. yield —
EV/EBIT —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.6
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 0.3
Interest cover -0.63×
Cash / Debt 1.8×
Debt payback 0.0 yr
Quick ratio 4.5×
Cash runway 2.7 yr
F-score 5.0 pts
Debt / Eq 3.5×
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.2
Sales/sh Y/Y +8.6%
Sales Q/Q +22.1%
Shares change +15.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.